Search results for "coronary occlusion"

showing 10 items of 59 documents

Flow cytometric analysis of peroxidative activity in granulocytes from coronary and peripheral blood in acute myocardial ischemia and reperfusion in …

1999

BACKGROUND Methionine has shown protective effects in experimental models of myocardial infarction and is highly reactive to oxidative compounds produced by polymorphonuclear leukocytes (PMN), which in turn have been associated with myocardial damage. We have investigated the effect of methionine administration on spontaneous leukocyte peroxidative activity in myocardial ischemia and reperfusion. METHODS In anesthetized dogs, with coronary occlusion (90 min) and reperfusion (90 min), PMN activation was measured by flow cytometric determination of H(2)O(2) with dihydrorhodamine 123, and correlated to hemodynamic parameters and infarct presence. To assess a possible direct effect of methionin…

Methioninemedicine.diagnostic_testChemistrySuperoxideBiophysicsHemodynamicsCell BiologyHematologyVenous bloodOxidative phosphorylationPharmacologyPathology and Forensic MedicineFlow cytometrychemistry.chemical_compoundEndocrinologyIn vivoCoronary occlusionmedicineCytometry
researchProduct

Metabolomic Profile of Human Myocardial Ischemia by Nuclear Magnetic Resonance Spectroscopy of Peripheral Blood Serum

2012

Objectives The aim of this study was to investigate the metabolomic profile of acute myocardial ischemia (MIS) using nuclear magnetic resonance spectroscopy of peripheral blood serum of swine and patients undergoing angioplasty balloon‐induced transient coronary occlusion. Background Biochemical detection of MIS is a major challenge. The validation of novel biosignatures is of utmost importance. Methods High-resolution nuclear magnetic resonance spectroscopy was used to profile 32 blood serum metabolites obtained (before and after controlled ischemia) from swine (n 9) and patients (n 20) undergoing transitory MIS in the setting of planned coronary angioplasty. Additionally, blood serum of c…

Pathologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentArea under the curveIschemiaInfarctionmedicine.diseaseChest painBlood serumCoronary occlusionInternal medicineAngioplastymedicineCardiologyBiomarker (medicine)medicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of the American College of Cardiology
researchProduct

Dual guidewire balloon antegrade fenestration and re‐entrytechnique for coronary chronic total occlusions percutaneouscoronary interventions

2022

Objectives:To describe the experience of coronary chronic total occlusions (CTOs)percutaneous coronary interventions (PCI) using antegrade fenestration and re‐entry(AFR) technique with a dedicated dual guidewire balloon (DGB).Background:Antegrade dissection and re‐entry (ADR) techniques has beenemphasized in recent worldwide CTO consensus documents. We investigated thefeasibility and safety of DGB as a dedicated device to perform guidewire‐based AFR.Methods and Results:Fourteen consecutive patients with complex CTO (J‐CTOscore: 3.1 ± 0.9) underwent DGB‐AFR in the years 2020–2021. DGB‐AFR consists inadvancing the DGB over a guidewire that reached the vessel distal to the CTO in anextra plaqu…

Percutaneous Coronary InterventionTreatment Outcomepercutaneous coronaryinterventionCoronary OcclusionChronic DiseaseHumansRadiology Nuclear Medicine and imagingwire‐based antegrade dissection re‐entryGeneral MedicineCoronary AngiographyCardiology and Cardiovascular Medicineantegrade fenestration and re‐entrychronic total occlusion
researchProduct

Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implanta…

2018

OBJECTIVES Transcatheter aortic valve implantation (TAVI) in patients with low coronary heights is generally denied but is not impossible. Information about these high-risk procedures is sparse. METHODS Since May 2008, data of more than 3000 patients who had TAVI were prospectively collected in the institutional TAVI Karlsruhe registry. Characteristics, peri- and postoperative outcome of patients with low coronary heights of ≤7 mm were analysed according to the Valve Academic Research Consortium-2. RESULTS Eighty-six patients with an average coronary height of 6.4 ± 1.1 mm (mean age 81.0 ± 5.3 years, logistic EuroSCORE I 19.6 ± 13.3%) were treated. TAVI was performed in 72 transfemoral (83.…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicinePostoperative ComplicationsValve replacementGermanyMedicineHumans030212 general & internal medicineProspective StudiesRegistriesProspective cohort studyAortic dissectionAged 80 and overBioprosthesisbusiness.industryMortality rateIncidenceHazard ratioExtracorporeal circulationPercutaneous coronary interventionGeneral MedicineAortic Valve Stenosismedicine.diseaseCoronary VesselsSurgerySurvival RateTreatment OutcomeCoronary OcclusionCoronary occlusionAortic ValveFluoroscopyFeasibility StudiesSurgeryFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Procedural characteristics and outcomes following chronic total occlusion coronary intervention: pooled analysis from 5 registries.

2021

Background Recent improvement in clinical skills, technology and hardware has resulted in improved success rates with chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We performed a study level pooled analysis from the five largest registries of percutaneous coronary intervention (PCI) of CTO. Research design and methods We conducted pooled analysis of 9500 patients in registries and data on procedural characteristics, technical success, and MACCE was collected. Results A total of 9500 patients were included in the analysis. Mean age was 65.4 years with previous CABG in 24.8%, reattempt procedure in 24.8% and mean JCTO score was 2.2. Final wiring strategy in hybrid al…

Research designmedicine.medical_specialtymedicine.medical_treatmentCoronary AngiographyTotal occlusionPercutaneous Coronary InterventionRisk FactorsCardiac tamponadeInternal medicineInternal MedicineMedicineHumansRegistriesStrokeAgedbusiness.industryPercutaneous coronary interventionGeneral Medicinemedicine.diseasePooled analysisTreatment OutcomeCoronary OcclusionConventional PCIChronic DiseaseCardiology and Cardiovascular MedicinebusinessComplicationExpert review of cardiovascular therapy
researchProduct

Coronary chronic total occlusions and mortality in patients with ventricular tachyarrhythmias.

2020

Aims This study sought to assess the prognostic impact of coronary chronic total occlusions (CTO) in patients presenting with ventricular tachyarrhythmias on admission. Methods and results A large retrospective registry was used, including all consecutive patients presenting with ventricular tachyarrhythmias on admission and undergoing coronary angiography from 2002 to 2016. Patients with a CTO were compared with all other patients (non-CTO) for prognostic outcomes. Statistics comprised Kaplan-Meier and Cox regression analyses. Within a total of 1,461 consecutive patients included with ventricular tachyarrhythmias on admission, a CTO was present in 20%. At midterm follow-up of 18 months, th…

Tachycardiamedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyCoronary artery disease03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRetrospective StudieRisk FactorsInternal medicinemedicineClinical endpointHumans030212 general & internal medicineMyocardial infarctionRisk stratificationRetrospective Studiesbusiness.industryMortality ratePercutaneous coronary interventionRetrospective cohort studymedicine.diseaseDeathTreatment OutcomeCoronary OcclusionCoronary occlusionCoronary chronic total occlusionChronic DiseaseCardiologyTachycardia Ventricularmedicine.symptomCardiology and Cardiovascular MedicinebusinessEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
researchProduct

Myocardial Glutathione Alterations in Acute Coronary Occlusion in the Dog

1987

Glutathione (GSH) decreases in dog mycocardium upon acute coronary occlusion when compared with sham-operated dogs. Total glutathione content (GSHeq = GSH + ZGSSG) remains unchanged throughout the experiment (6 h after surgery) in both sham- and acute coronary occlusion-operated dogs. GSSG and GSH/GSSG ratio increases and decreases respectively in all animals but tends to reach the normal value after 6 h in sham-operated dogs. Both parameters (GSSG and GSH/GSSG ratio) remain altered in acute coronary occlusion-operated ones. This alteration of glutathione status in ischemic myocardium is discussed.

inorganic chemicalsmedicine.medical_specialtyIschemic myocardiumIschemiaCoronary DiseaseBiochemistrychemistry.chemical_compoundDogsfluids and secretionsReference ValuesInternal medicinemedicineAnimalsNormal rangeGlutathione DisulfideTotal glutathionebusiness.industryMyocardiumGlutathionemedicine.diseaseCoronary VesselsGlutathioneKineticschemistryCoronary occlusionAnesthesiaCardiologybusinessFree Radical Research Communications
researchProduct

Global Chronic Total Occlusion Crossing Algorithm

2021

© 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC By-NC-ND License (http://creativecommons.org/licenses/by-nc-nd/4)

medicine.diagnostic_testAlgoritmosbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionGlobalState of the art reviewCollateral circulationTotal occlusionPercutaneous coronary interventionCatheterChronic total occlusionCoronary OcclusionIntravascular ultrasoundOcclusionAngiographyTreatment algorithmMedicineOclusão CoronáriaCardiology and Cardiovascular MedicinebusinessAlgorithmAlgorithms
researchProduct

Effect of chronic exercise and ATP-sensitive potassium channel blockade on the spectral characteristics evolution of ventricular fibrillation in acut…

2013

Purpose: It has been proposed that chronic exercise produces a KATP channel blockade in ischemic myocardium. We have also reported that channel blockade and training exert very similar effects on energy required to defibrillate. In fact it is postulated that one mechanism by which exercise exerts an antiarrhythmic effect, is by blocking KATP channel. We have analyzed the evolution of spectrum characteristics of ventricular fibrillation (VF), in normoxic conditions and after acute myocardial ischemia, in isolated hearts from trained rabbits, and in hearts submitted to KATP channel blockade. Our hypothesis is that the spectrum characteristics of VF evolve similarly in trained hearts and in he…

medicine.medical_specialtyATP-sensitive potassium channelbusiness.industryIschemiamedicine.diseaseBlockadeGlibenclamidemedicine.anatomical_structureVentricleCoronary occlusionAnesthesiaInternal medicineVentricular fibrillationCardiologymedicineCardiology and Cardiovascular MedicinebusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Heart Journal
researchProduct

Role of antiangiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction

2021

Abstract Introduction and objectives Angiogenesis helps to reestablish microcirculation after myocardial infarction (MI). In this study, we aimed to further understand the role of the antiangiogenic isoform vascular endothelial growth factor (VEGF)-A165b after MI and to explore its potential as a coadjuvant therapy to coronary reperfusion. Methods Two mice MI models were formed: a) permanent coronary ligation (nonreperfused MI); b) transient 45-minute coronary occlusion followed by reperfusion (reperfused MI); in both models, animals underwent echocardiography before euthanasia at day 21 after MI induction. We determined serum and myocardial VEGF-A165b levels. In both experimental MI models…

medicine.medical_specialtyEjection fractionbusiness.industryAngiogenesisGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseMicrocirculationBlockadeVascular endothelial growth factor03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistryCoronary occlusionHeart failureInternal medicinemedicineCardiologyMyocardial infarctionbusinessRevista Española de Cardiología (English Edition)
researchProduct